Cover Page Document
Cover Page Document | Feb. 02, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Feb. 2, 2022 |
Entity Registrant Name | Revance Therapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-36297 |
Entity Tax Identification Number | 77-0551645 |
Entity Address, Address Line One | 1222 Demonbreun Street, Suite 2000 |
Entity Address, City or Town | Nashville |
Entity Address, State or Province | TN |
Entity Address, Postal Zip Code | 37203 |
City Area Code | 615 |
Local Phone Number | 724-7755 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | RVNC |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001479290 |
Amendment Flag | false |